Quantcast

Latest Bioethics Stories

2014-02-25 08:31:00

- Study Meets Primary and Both Key Secondary Endpoints - BRISBANE, Calif., Feb. 25, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that top-line data from ASCEND, a Phase 3 trial evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF), demonstrated that pirfenidone significantly reduced IPF disease progression as measured by change in percent predicted forced vital capacity (FVC) from Baseline to Week 52 (rank ANCOVA p<0.000001)....

2014-02-18 08:29:35

MELBOURNE, Australia and NEW YORK, Feb. 18, 2014 /PRNewswire/ -- Key Points: -- Primary endpoints of safety and tolerability met. -- Secondary endpoint: Statistically significant improvement in a measure of executive function(cognition) in research participants administered 250mg PBT2 daily (p=0.042). -- PBT2 250mg was also associated with a favourable signal in functional capacity. -- Preliminary evidence suggests PBT2 250mg reduced atrophy of...

2014-02-14 23:01:28

Results from Alpha BRAIN™ Pilot Study to Be Presented at the International Neuropsychological Society Annual Conference Austin, Texas (PRWEB) February 14, 2014 Results from a pilot study entitled “A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of Alpha BRAIN™ Administered Orally,” conducted by the Boston Center for Memory will be presented at the annual International Neuropsychological Society (INS) meeting in Seattle,...

2014-02-13 23:26:17

All proceeds from this special photo shoot will benefit homeless dogs and cats. Washington, DC (PRWEB) February 13, 2014 Lucky Dog Animal Rescue and Houndstooth Photography will be holding a Valentine’s Photo shoot on Saturday, February 15th at Wagtime, 1232 9th Street, NW, Washington, DC. The shoot will be from 11 am to 1 pm. The $35 dollar sitting fee will be donated to Lucky Dog Animal Rescue. Prints can be ordered from Houndstooth Photography for an additional charge. Pet...

2014-02-11 23:30:44

The nonprofit organization, Animals for Armed Forces® Foundation, appreciates the support of Julian Omidi and Dr. Michael Omidi and their charity Animal Support. They look forward to expanding their calendar of free pet adoption events for members of the United States military. (PRWEB) February 11, 2014 Animal Support and its charity cofounders, Dr. Michael Omidi and Julian Omidi, recently received the thanks for supporting the work of Animals for Armed Forces Foundation®, a...

2014-02-11 08:32:36

Company continues to expand its board and leadership team as it moves toward completion of its Phase 3 gene therapy program and advancement of the industry's deepest pipeline of gene-based medicines PHILADELPHIA, Feb. 11, 2014 /PRNewswire/ -- Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today the appointment of Elliott Sigal, M.D., Ph.D., former director, executive vice president and chief scientific officer of...

2014-02-11 08:27:28

SEATTLE, Feb. 11, 2014 /PRNewswire-USNewswire/ -- Are humans the enemy? Should pigs and peas have constitutional rights? The War on Humans, a provocative 31-minute documentary from Discovery Institute exploring growing efforts to disparage the value of humans in the name of saving the planet, will be released online February 18(th) at www.waronhumans.com. The documentary features bioethicist and Discovery Institute Senior Fellow Wesley J. Smith, who has authored a companion e-book...

2014-02-10 04:21:31

DUBLIN, February 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wlcf6t/mice_model_market) has announced the addition of the "Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018" [http://www.researchandmarkets.com/research/wlcf6t/mice_model_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Over the years, the use of mice models...

2014-02-05 08:28:42

Presentation to be Webcast Live on February 10, 2014 at 3 PM EST PRINCETON, N.J., Feb. 5, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD,...

2014-02-03 04:22:20

COLOGNE, Germany, February 3, 2014 /PRNewswire/ -- Highly-effective unknown doping agents have emerged; cannot be tested A few days before the opening of the Winter Olympics in Sochi, WDR research has revealed serious doubts about a credible anti-doping campaign in the Olympics' host country. In the ARD Sports Show (ARD, today, February 2, 2014, 18:00) and the WDR broadcast "Sport Inside" (WDR evening, February 3, 2014, 22:55), WDR reporters cover encounters of a...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related